Monogram Orthopaedics (MGRM) Expected to Announce Earnings on Monday

Monogram Orthopaedics (NASDAQ:MGRM) is expected to post its Q1 2025 quarterly earnings results before the market opens on Monday, May 12th. Analysts expect the company to announce earnings of ($0.10) per share for the quarter.

Monogram Orthopaedics (NASDAQ:MGRM) last released its quarterly earnings results on Wednesday, March 12th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.03. On average, analysts expect Monogram Orthopaedics to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Monogram Orthopaedics Stock Up 0.7 %

Shares of MGRM stock opened at $2.69 on Friday. Monogram Orthopaedics has a 52-week low of $1.87 and a 52-week high of $4.21. The stock’s 50-day moving average price is $2.73 and its 200 day moving average price is $2.54. The stock has a market capitalization of $94.93 million, a PE ratio of -5.72 and a beta of 0.74.

Wall Street Analysts Forecast Growth

MGRM has been the topic of a number of analyst reports. Roth Mkm lifted their price objective on shares of Monogram Orthopaedics from $4.00 to $5.40 and gave the company a “buy” rating in a research report on Tuesday, March 18th. Roth Capital set a $5.40 price target on shares of Monogram Orthopaedics in a research note on Tuesday, March 18th.

About Monogram Orthopaedics

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.